[
  {
    "ts": "2026-01-20T00:12:50+00:00",
    "headline": "Pfizer (PFE) Valuation Check As Investors Reassess Recent Shareholder Returns",
    "summary": "Why Pfizer (PFE) Is Back on Investors’ Radar Pfizer (PFE) is attracting fresh attention after a period of mixed share performance, with the stock showing positive total returns over the past year despite weaker recent annual revenue and net income growth. See our latest analysis for Pfizer. Recent trading has been relatively steady, with a 90 day share price return of 3.22% and a 1 year total shareholder return of 4.59%, contrasting with a weaker 3 year total shareholder return of 32.17%...",
    "url": "https://finance.yahoo.com/news/pfizer-pfe-valuation-check-investors-001250364.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "5547d1a8-a5f7-3fa7-bd0a-6077cb9eaad2",
      "content": {
        "id": "5547d1a8-a5f7-3fa7-bd0a-6077cb9eaad2",
        "contentType": "STORY",
        "title": "Pfizer (PFE) Valuation Check As Investors Reassess Recent Shareholder Returns",
        "description": "",
        "summary": "Why Pfizer (PFE) Is Back on Investors’ Radar Pfizer (PFE) is attracting fresh attention after a period of mixed share performance, with the stock showing positive total returns over the past year despite weaker recent annual revenue and net income growth. See our latest analysis for Pfizer. Recent trading has been relatively steady, with a 90 day share price return of 3.22% and a 1 year total shareholder return of 4.59%, contrasting with a weaker 3 year total shareholder return of 32.17%...",
        "pubDate": "2026-01-20T00:12:50Z",
        "displayTime": "2026-01-20T00:12:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfydsi7Q.1zNEN99DbEyw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hi2p7oczHh8yTJraqZcczg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-valuation-check-investors-001250364.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-valuation-check-investors-001250364.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-20T07:54:16+00:00",
    "headline": "Texas, N. Carolina, Ohio, Pennsylvania — where pharma manufacturing investments have surged",
    "summary": "Pledged projects have landed in a handful of hotspots while giving rise to potential new hubs across the U.S.",
    "url": "https://www.pharmavoice.com/news/drug-pharma-manufacturing-hub-lilly-amgen-novartis/809904/",
    "source": "Pharma Voice",
    "provider": "yfinance",
    "raw": {
      "id": "f3e422c6-56b3-39b2-87a9-b9367723deae",
      "content": {
        "id": "f3e422c6-56b3-39b2-87a9-b9367723deae",
        "contentType": "STORY",
        "title": "Texas, N. Carolina, Ohio, Pennsylvania — where pharma manufacturing investments have surged",
        "description": "",
        "summary": "Pledged projects have landed in a handful of hotspots while giving rise to potential new hubs across the U.S.",
        "pubDate": "2026-01-20T07:54:16Z",
        "displayTime": "2026-01-20T07:54:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharma_voice_330/6bec6c4c3efa1bd87baa9156bf48a181",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6aEq7cm4UAKo_VT7AcDTEw--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/6bec6c4c3efa1bd87baa9156bf48a181.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5RrtotuTpMEg5BLobnZlEA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharma_voice_330/6bec6c4c3efa1bd87baa9156bf48a181.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharma Voice",
          "url": "https://www.pharmavoice.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmavoice.com/news/drug-pharma-manufacturing-hub-lilly-amgen-novartis/809904/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/texas-n-carolina-ohio-pennsylvania-075416250.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "RHHBF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-20T15:00:00+00:00",
    "headline": "Abcam joins the Innovative Health Initiative LIGAND-AI project to advance artificial intelligence (AI)-driven drug discovery through open science",
    "summary": "Abcam and the other 17 members of the partnership today launched the IHI project, LIGAND-AI, to advance AI-driven drug discovery through open science.",
    "url": "https://finance.yahoo.com/news/abcam-joins-innovative-health-initiative-150000622.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "fa41c586-e9c8-3617-9421-ed17eff09f51",
      "content": {
        "id": "fa41c586-e9c8-3617-9421-ed17eff09f51",
        "contentType": "STORY",
        "title": "Abcam joins the Innovative Health Initiative LIGAND-AI project to advance artificial intelligence (AI)-driven drug discovery through open science",
        "description": "",
        "summary": "Abcam and the other 17 members of the partnership today launched the IHI project, LIGAND-AI, to advance AI-driven drug discovery through open science.",
        "pubDate": "2026-01-20T15:00:00Z",
        "displayTime": "2026-01-20T15:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/c57600d179697538247ca9776eb6a64f",
          "originalWidth": 400,
          "originalHeight": 87,
          "caption": "Our mission: to help accelerate the next breakthrough in drug discovery, diagnostics and basic research.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qR8UZF3NfvMamwFbwkrHJw--~B/aD04Nzt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/c57600d179697538247ca9776eb6a64f.cf.webp",
              "width": 400,
              "height": 87,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5F_ogDt4bfOsAZ30UtC0w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c57600d179697538247ca9776eb6a64f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abcam-joins-innovative-health-initiative-150000622.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abcam-joins-innovative-health-initiative-150000622.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-20T13:08:00+00:00",
    "headline": "Which Pharma Stock Stands Taller Right Now: LLY or PFE?",
    "summary": "Eli Lilly's Mounjaro and Zepbound fuel rapid growth as new launches and an oral GLP-1 near approval shape its investment case against peers.",
    "url": "https://finance.yahoo.com/news/pharma-stock-stands-taller-now-130800136.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "fe8f4130-c095-3882-91de-dbb4601937e4",
      "content": {
        "id": "fe8f4130-c095-3882-91de-dbb4601937e4",
        "contentType": "STORY",
        "title": "Which Pharma Stock Stands Taller Right Now: LLY or PFE?",
        "description": "",
        "summary": "Eli Lilly's Mounjaro and Zepbound fuel rapid growth as new launches and an oral GLP-1 near approval shape its investment case against peers.",
        "pubDate": "2026-01-20T13:08:00Z",
        "displayTime": "2026-01-20T13:08:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A9LQHlDmqgPJbKsotfjd8w--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o5.ym16dSp_UIlCHMRMZUw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pharma-stock-stands-taller-now-130800136.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pharma-stock-stands-taller-now-130800136.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-20T15:41:06+00:00",
    "headline": "Novavax Licenses Rights to Key Vaccine Component to Pfizer",
    "summary": "Novavax, the Covid-19 vaccine maker, has licensed the rights for a vaccine-enhancing component to Pfizer.  Pfizer agreed to pay $30 million upfront, and could pay up to $500 million more if development and sales milestones are reached, plus royalties, Novavax said.  Pfizer, which makes an mRNA-based Covid-19 vaccine, is licensing Novavax’s adjuvant, called “Matrix-M,” which is a substance that can enhance the potency of a vaccine.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-netflix-01-20-2026/card/novavax-licenses-rights-to-key-vaccine-component-to-pfizer-TNPHEhGWrpIzFhRJ8hki?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "35d33763-811b-380e-b913-f4416e59356e",
      "content": {
        "id": "35d33763-811b-380e-b913-f4416e59356e",
        "contentType": "STORY",
        "title": "Novavax Licenses Rights to Key Vaccine Component to Pfizer",
        "description": "",
        "summary": "Novavax, the Covid-19 vaccine maker, has licensed the rights for a vaccine-enhancing component to Pfizer.  Pfizer agreed to pay $30 million upfront, and could pay up to $500 million more if development and sales milestones are reached, plus royalties, Novavax said.  Pfizer, which makes an mRNA-based Covid-19 vaccine, is licensing Novavax’s adjuvant, called “Matrix-M,” which is a substance that can enhance the potency of a vaccine.",
        "pubDate": "2026-01-20T15:41:06Z",
        "displayTime": "2026-01-20T15:41:06Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/35d33763-811b-380e-b913-f4416e59356e/novavax-licenses-rights-to.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
          "originalWidth": 1200,
          "originalHeight": 630,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AC.ajdS9OghfMNW3mzlvpg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 1200,
              "height": 630,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5JxVR9DmLuomtxdXBS7Uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-netflix-01-20-2026/card/novavax-licenses-rights-to-key-vaccine-component-to-pfizer-TNPHEhGWrpIzFhRJ8hki?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVAX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-20T15:30:17+00:00",
    "headline": "BC-Most Active Stocks",
    "summary": "td class=\"col-issue\">New Era Energy & Digital Inc.",
    "url": "https://finance.yahoo.com/news/bc-most-active-stocks-153017333.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "7b0802d1-3bd8-3afa-89a7-f7c0327aa089",
      "content": {
        "id": "7b0802d1-3bd8-3afa-89a7-f7c0327aa089",
        "contentType": "STORY",
        "title": "BC-Most Active Stocks",
        "description": "",
        "summary": "td class=\"col-issue\">New Era Energy & Digital Inc.",
        "pubDate": "2026-01-20T15:30:17Z",
        "displayTime": "2026-01-20T15:30:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bc-most-active-stocks-153017333.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bc-most-active-stocks-153017333.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IBRX"
            },
            {
              "symbol": "IVF"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "ICON"
            },
            {
              "symbol": "NTCL"
            },
            {
              "symbol": "DVLT"
            },
            {
              "symbol": "MU"
            },
            {
              "symbol": "PLUG"
            },
            {
              "symbol": "AKAN"
            },
            {
              "symbol": "RAPT"
            },
            {
              "symbol": "RMTI"
            },
            {
              "symbol": "IREN"
            },
            {
              "symbol": "SIDU"
            },
            {
              "symbol": "APLD"
            },
            {
              "symbol": "THH"
            },
            {
              "symbol": "WMT"
            },
            {
              "symbol": "RGTI"
            },
            {
              "symbol": "OPEN"
            },
            {
              "symbol": "USAR"
            },
            {
              "symbol": "DXST"
            },
            {
              "symbol": "SOFI"
            },
            {
              "symbol": "RIOT"
            },
            {
              "symbol": "CLSK"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "NVTS"
            },
            {
              "symbol": "RIVN"
            },
            {
              "symbol": "CIFR"
            },
            {
              "symbol": "EVTV"
            },
            {
              "symbol": "EOSE"
            },
            {
              "symbol": "RXRX"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "MSTR"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "CCHH"
            },
            {
              "symbol": "INTC"
            },
            {
              "symbol": "ATON"
            },
            {
              "symbol": "CRVS"
            },
            {
              "symbol": "POLA"
            },
            {
              "symbol": "ASST"
            },
            {
              "symbol": "ETH-USD"
            },
            {
              "symbol": "IBIT"
            },
            {
              "symbol": "MARA"
            },
            {
              "symbol": "SMCI"
            },
            {
              "symbol": "GRAB"
            },
            {
              "symbol": "BITF"
            },
            {
              "symbol": "IVP"
            },
            {
              "symbol": "BYND"
            },
            {
              "symbol": "RZLV"
            },
            {
              "symbol": "ORCL"
            },
            {
              "symbol": "LAC"
            },
            {
              "symbol": "JOBY"
            },
            {
              "symbol": "NU"
            },
            {
              "symbol": "PL"
            },
            {
              "symbol": "IMG.TO"
            },
            {
              "symbol": "OGN"
            },
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "BTTC"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "SDST"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "BBAI"
            },
            {
              "symbol": "RR"
            },
            {
              "symbol": "SNDK"
            },
            {
              "symbol": "SOUN"
            },
            {
              "symbol": "BTBT"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "NBIS"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "POET"
            },
            {
              "symbol": "QUBT"
            },
            {
              "symbol": "WULF"
            },
            {
              "symbol": "HBAN"
            },
            {
              "symbol": "CGC"
            },
            {
              "symbol": "AGNC"
            },
            {
              "symbol": "CMCSA"
            },
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "RCAT"
            },
            {
              "symbol": "HIVE"
            },
            {
              "symbol": "LAES"
            },
            {
              "symbol": "PSTV"
            },
            {
              "symbol": "JAGX"
            },
            {
              "symbol": "APP"
            },
            {
              "symbol": "JTAI"
            },
            {
              "symbol": "NVAX"
            },
            {
              "symbol": "AAL"
            },
            {
              "symbol": "SEGG"
            },
            {
              "symbol": "FAST"
            },
            {
              "symbol": "GERN"
            },
            {
              "symbol": "ABTC"
            },
            {
              "symbol": "META"
            },
            {
              "symbol": "NVAC"
            },
            {
              "symbol": "QS"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "RDW"
            },
            {
              "symbol": "HL"
            },
            {
              "symbol": "AG"
            },
            {
              "symbol": "CDE"
            },
            {
              "symbol": "TE"
            },
            {
              "symbol": "F"
            },
            {
              "symbol": "SMR"
            },
            {
              "symbol": "JHX"
            },
            {
              "symbol": "ACHR"
            },
            {
              "symbol": "SNAP"
            },
            {
              "symbol": "EXK"
            },
            {
              "symbol": "NCLH"
            },
            {
              "symbol": "UWMC"
            },
            {
              "symbol": "VZ"
            },
            {
              "symbol": "RKT"
            },
            {
              "symbol": "QBTS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-20T14:38:00+00:00",
    "headline": "CorMedix vs. Mirum Pharma: Which Rare-Disease Stock is the Better Buy?",
    "summary": "CRMD and MIRM are advancing niche therapies with strong launches, rising sales and strategic acquisitions shaping their growth.",
    "url": "https://finance.yahoo.com/news/cormedix-vs-mirum-pharma-rare-143800787.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "632489c5-4ecb-38e3-8ceb-e030df7d1c4a",
      "content": {
        "id": "632489c5-4ecb-38e3-8ceb-e030df7d1c4a",
        "contentType": "STORY",
        "title": "CorMedix vs. Mirum Pharma: Which Rare-Disease Stock is the Better Buy?",
        "description": "",
        "summary": "CRMD and MIRM are advancing niche therapies with strong launches, rising sales and strategic acquisitions shaping their growth.",
        "pubDate": "2026-01-20T14:38:00Z",
        "displayTime": "2026-01-20T14:38:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/5d53490d96d857e2597369efd142a916",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HT9dcJW2gBb88_fWbEkPdQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d53490d96d857e2597369efd142a916.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5ysuZYz59NJOpcHkYE2XYA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d53490d96d857e2597369efd142a916.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cormedix-vs-mirum-pharma-rare-143800787.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cormedix-vs-mirum-pharma-rare-143800787.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRMD"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MIRM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-20T17:14:06+00:00",
    "headline": "Shionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up",
    "summary": "Pfizer exits ViiV Healthcare with a $1.89bn payout, while GSK retains its majority stake amid the shareholder shake-up.",
    "url": "https://www.pharmaceutical-technology.com/news/shionogi-expands-viiv-healthcare-stake-by-2-13bn-as-pfizer-sells-up/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "fc6c30ec-86da-3677-be4d-e871f578042a",
      "content": {
        "id": "fc6c30ec-86da-3677-be4d-e871f578042a",
        "contentType": "STORY",
        "title": "Shionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up",
        "description": "",
        "summary": "Pfizer exits ViiV Healthcare with a $1.89bn payout, while GSK retains its majority stake amid the shareholder shake-up.",
        "pubDate": "2026-01-20T17:14:06Z",
        "displayTime": "2026-01-20T17:14:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/70d5ec5c84db91e16799f9a836063ad6",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CHnnvK15IvggtepkxHV7Wg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/70d5ec5c84db91e16799f9a836063ad6.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/08hRt4x6sfRmgzC4FG8tvw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/70d5ec5c84db91e16799f9a836063ad6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/shionogi-expands-viiv-healthcare-stake-by-2-13bn-as-pfizer-sells-up/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/shionogi-expands-viiv-healthcare-stake-171406934.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SGIOF"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-20T20:29:00+00:00",
    "headline": "Executive Coach Michael King Releases Music Video \"Unbreakable Things\" on Leadership Identity",
    "summary": "The project addresses imposter syndrome and resilience in high-performing executivesOmaha, Nebraska, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Michael King, executive coach and founder of Teams.Coach, has released a music video titled \"Unbreakable Things\" that addresses imposter syndrome and identity challenges facing executives. King has worked with Disney, Pfizer, The YMCA and other Fortune 500 companies through his coaching practice. The music video presents a framework King calls identity reclamatio",
    "url": "https://finance.yahoo.com/news/executive-coach-michael-king-releases-202900264.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "2528ef86-e8ff-3276-b545-d934e44e07ee",
      "content": {
        "id": "2528ef86-e8ff-3276-b545-d934e44e07ee",
        "contentType": "STORY",
        "title": "Executive Coach Michael King Releases Music Video \"Unbreakable Things\" on Leadership Identity",
        "description": "",
        "summary": "The project addresses imposter syndrome and resilience in high-performing executivesOmaha, Nebraska, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Michael King, executive coach and founder of Teams.Coach, has released a music video titled \"Unbreakable Things\" that addresses imposter syndrome and identity challenges facing executives. King has worked with Disney, Pfizer, The YMCA and other Fortune 500 companies through his coaching practice. The music video presents a framework King calls identity reclamatio",
        "pubDate": "2026-01-20T20:29:00Z",
        "displayTime": "2026-01-20T20:29:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/5cdb5a2952ea2f20ca1f9116b93e2e49",
          "originalWidth": 185,
          "originalHeight": 185,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qCgtw3UDmvrggUG2aQOvvg--~B/aD0xODU7dz0xODU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5cdb5a2952ea2f20ca1f9116b93e2e49.cf.webp",
              "width": 185,
              "height": 185,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.K2tuCGgSIBKMyY69Wk3Cw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5cdb5a2952ea2f20ca1f9116b93e2e49.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/executive-coach-michael-king-releases-202900264.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/executive-coach-michael-king-releases-202900264.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DIS"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-20T18:41:00+00:00",
    "headline": "BMY vs GSK: Which Biopharma Giant Has Better Prospects for Now?",
    "summary": "Bristol Myers Squibb and GSK stack up differently on growth, debt, pipelines and returns, making the stock-picking decision far from obvious",
    "url": "https://finance.yahoo.com/news/bmy-vs-gsk-biopharma-giant-184100365.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "d3dd425f-e413-349d-a24d-610598e626e7",
      "content": {
        "id": "d3dd425f-e413-349d-a24d-610598e626e7",
        "contentType": "STORY",
        "title": "BMY vs GSK: Which Biopharma Giant Has Better Prospects for Now?",
        "description": "",
        "summary": "Bristol Myers Squibb and GSK stack up differently on growth, debt, pipelines and returns, making the stock-picking decision far from obvious",
        "pubDate": "2026-01-20T18:41:00Z",
        "displayTime": "2026-01-20T18:41:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xubTnAbsCPnw2obvb7FmXA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lcL5Qr7_.1czomowImosdw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmy-vs-gsk-biopharma-giant-184100365.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmy-vs-gsk-biopharma-giant-184100365.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "GLAXF"
            },
            {
              "symbol": "GSK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-20T17:53:30+00:00",
    "headline": "Novavax Pops on Pfizer Licensing Deal",
    "summary": "Matrix-M agreement adds cash and royalties",
    "url": "https://finance.yahoo.com/news/novavax-pops-pfizer-licensing-deal-175330762.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "645a751c-84c1-3056-ab5b-210bc88bbe91",
      "content": {
        "id": "645a751c-84c1-3056-ab5b-210bc88bbe91",
        "contentType": "STORY",
        "title": "Novavax Pops on Pfizer Licensing Deal",
        "description": "",
        "summary": "Matrix-M agreement adds cash and royalties",
        "pubDate": "2026-01-20T17:53:30Z",
        "displayTime": "2026-01-20T17:53:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/44ed03f521915de02624ee49ad5a963a",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8NRl4nvN1jQLfJzcg51GhQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/44ed03f521915de02624ee49ad5a963a.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/73rwfb.ojnUsltXki4SurA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/44ed03f521915de02624ee49ad5a963a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novavax-pops-pfizer-licensing-deal-175330762.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novavax-pops-pfizer-licensing-deal-175330762.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVAX"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-20T21:57:00+00:00",
    "headline": "Health Care Roundup: Market Talk",
    "summary": "Find insight on GSK’s acquisition of RAPT Therapeutics, Novartis and more in the latest Market Talks covering Health Care.",
    "url": "https://www.wsj.com/articles/health-care-roundup-market-talk-16df1170?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "30fba367-1b13-3931-b154-39c7b5e7f0b5",
      "content": {
        "id": "30fba367-1b13-3931-b154-39c7b5e7f0b5",
        "contentType": "STORY",
        "title": "Health Care Roundup: Market Talk",
        "description": "",
        "summary": "Find insight on GSK’s acquisition of RAPT Therapeutics, Novartis and more in the latest Market Talks covering Health Care.",
        "pubDate": "2026-01-20T21:57:00Z",
        "displayTime": "2026-01-20T21:57:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/30fba367-1b13-3931-b154-39c7b5e7f0b5/health-care-roundup-market.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/bd45e130fb5d221ae0c46fc72b2041d5",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ARM0GrkFQuANPgLprIGrwA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/bd45e130fb5d221ae0c46fc72b2041d5.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AsLL0hd96VZM1Aq90rZ1Kg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/bd45e130fb5d221ae0c46fc72b2041d5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/articles/health-care-roundup-market-talk-16df1170?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]